Attorney general urges New Jerseyans to check, file claim for awards if they bought listed off-brand prescription medicines over 10 years

Sherrill deserves credit for standing against middlemen-like practices that limit drug access, and now lawmakers must follow through

Greater regulation urged of pharmacy benefit managers, drug-supply middlemen

NJ bill would mandate insurance coverage without prior authorization or ‘step therapy’

Copay accumulator adjuster programs are ‘bleeding patients dry’

The 340B program’ is being exploited by many large, nonprofit health systems, including some in New Jersey’

Democrats challenge Robert F. Kennedy Jr., President Trump’s controversial nominee for health secretary, over shifting positions

New Prescription Drug Affordability Council must take a balanced approach that helps patients without harming potential cures

Some NJ lawmakers push to ban prior authorization and ‘step therapy’ protocols for people with serious mental illnesses

We should pursue proven policies that work, not ones that won’t make a difference for patients and risk serious harm to jobs and the economy

State and federal authorities have new powers to examine pricing and negotiate for lower costs but there are impediments

New negotiated prices would not take effect until 2026

Recent survey found more than 90% of cancer centers reported shortages of commonly used chemotherapy drugs

Governor proposes $53.1 billion plan, 5% increase over last year’s budget

Expanded tax relief, more help paying for prescriptions and hearing aids

NJ senator says the measure will lower cost of prescription drugs, energy, health care

It's the first of its kind in New Jersey

NJ lawmakers consider legislation to make prescription drugs more affordable

Gov. Phil Murphy announced his support for a package of four bills that address affordability issues

U.S. Rep. Andy Kim and local advocates joined Protect Our Care New Jersey for a virtual press conference to draw attention to high drug prices